Products for Research Use Only
RegisterLogin

PD-L1 inhibitory peptide

CAT: 0804-HY-P10950Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10950Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PD-L1 inhibitory peptide is an inhibitor peptide targeting programmed cell death ligand 1 (PD-L1) . PD-L1 inhibitory peptide binds to PD-L1, relieving immunosuppression and restoring the antitumor activity of T cells. PD-L1 inhibitory peptide is promising for research of cancers[1][2].
CAS Number
1931111-41-9
UNSPSC
12352209
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation
Field of Research
Cancer; Inflammation/Immunology
Smiles
OC(CN1C2=CC=CC=C2C(C[C@H]3C(N([C@H](C(N([C@H](C(N[C@H](C(N[C@@H](CSCC(N[C@H](C(N([C@H](C(N[C@H](C(N4[C@](CCC4)([H])C(N[C@H](C(N[C@H](C(N5[C@](C[C@H](C5)O)([H])C(N[C@H](C(N[C@H](C(N3)=O)CCN)=O)CC6=CNC7=CC=CC=C67)=O)=O)CC(C)C)=O)CN)=O)=O)CC(N)=O)=O)C)C)=O)CC8=CC=C(C=C8)O)=O)C(NCC(N[C@H](C(O)=O)CC#C)=O)=O)=O)CC(C)C)=O)CCCC)C)=O)CCCC)C)=O)=C1)=O
Molecular Formula
C96H135N21O23S
Molecular Weight
1983.29
References & Citations
[1]Shindo Y, et al. Anti-PD-L1 peptide improves survival in sepsis[J]. Journal of Surgical Research, 2017, 208: 33-39.|[2]Boohaker RJ, et al. Rational design and development of a peptide inhibitor for the PD-1/PD-L1 interaction. Cancer Lett. 2018 Oct 10;434:11-21.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported

Chemical Information

PD-L1 inhibitory peptide
CAS Number1931111-41-9
PubChem CID134384166
IUPAC Name(2S)-2-[[2-[[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48S,50R)-42-(2-aminoethyl)-6-(aminomethyl)-15-(2-amino-2-oxoethyl)-33,36-dibutyl-39-[[1-(carboxymethyl)indol-3-yl]methyl]-50-hydroxy-21-[(4-hydroxyphenyl)methyl]-45-(1H-indol-3-ylmethyl)-18,19,34,37-tetramethyl-3,30-bis(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carbonyl]amino]acetyl]amino]pent-4-ynoic acid
Molecular FormulaC96H135N21O23S
Molecular Weight1983.3
XLogP-2.2
Topological Polar Surface Area678
Hydrogen Bond Donor Count19
Hydrogen Bond Acceptor Count26
Rotatable Bond Count29
Heavy Atom Count141
Formal Charge0
Complexity4420
SMILES
CCCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSCC(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N1C)CCCC)C)CC4=CN(C5=CC=CC=C54)CC(=O)O)CCN)CC6=CNC7=CC=CC=C76)O)CC(C)C)CN)CC(=O)N)C)C)CC8=CC=C(C=C8)O)C(=O)NCC(=O)N[C@@H](CC#C)C(=O)O)CC(C)C
InChI
InChI=1S/C96H135N21O23S/c1-12-15-26-74-88(131)105-65(37-52(4)5)85(128)111-72(83(126)101-46-79(121)102-64(22-14-3)96(139)140)50-141-51-80(122)103-68(39-55-30-32-58(118)33-31-55)91(134)112(9)54(8)82(125)107-70(43-78(99)120)93(136)116-36-21-29-75(116)89(132)110-71(44-98)87(130)108-67(38-53(6)7)94(137)117-48-59(119)42-77(117)90(133)106-66(40-56-45-100-62-25-19-17-23-60(56)62)86(129)104-63(34-35-97)84(127)109-69(92(135)114(11)76(27-16-13-2)95(138)113(74)10)41-57-47-115(49-81(123)124)73-28-20-18-24-61(57)73/h3,17-20,23-25,28,30-33,45,47,52-54,59,63-72,74-77,100,118-119H,12-13,15-16,21-22,26-27,29,34-44,46,48-51,97-98H2,1-2,4-11H3,(H2,99,120)(H,101,126)(H,102,121)(H,103,122)(H,104,129)(H,105,131)(H,106,133)(H,107,125)(H,108,130)(H,109,127)(H,110,132)(H,111,128)(H,123,124)(H,139,140)/t54-,59+,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,74-,75-,76-,77-/m0/s1
InChIKey
YZIXAMWYVQPTNK-BFHZYFNMSA-N
Chemical Structure
2D Structure
2D structure of PD-L1 inhibitory peptide
CAS: 1931111-41-9
CID: 134384166
Formula: C96H135N21O23S
MW: 1983.3
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight1983.3
XLogP3-2.2
Hydrogen Bond Donor Count19
Hydrogen Bond Acceptor Count26
Rotatable Bond Count29
Exact Mass1982.97939565
Monoisotopic Mass1981.97604081
Topological Polar Surface Area678 Ų
Heavy Atom Count141
Formal Charge0
Complexity4420
Isotope Atom Count0
Defined Atom Stereocenter Count16
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-144649PD-1/PD-L1-IN-24
HY-132202-01PD-1/PD-L1-IN-10
HY-144442PD-1/PD-L1-IN-15
HY-129172APD-1/PD-L1-IN 5
HY-145770PD-1/PD-L1-IN-19
HY-179180PD-1/PD-L1-IN-59
HY-175702PD-1/PD-L1-IN-57
HY-144447PD-1/PD-L1-IN-17
HY-169190PD-1/PD-L1-IN-53
HY-144746PD-1/PD-L1-IN-26

Alternative Products

CatalogName
T207654-01PD-L1 inhibitory peptide
TP3811-01PD-L1 inhibitory peptide TFA
TP3029-01PD-1/PD-L1 inhibitory peptide C8
148859S100A9, Control Peptide (S100 Calcium Binding Protein A9, 60B8AG, Calgranulin B, CAGB, Calprotectin L1H Subunit, CFAG, CGLB, Cystic Fibrosis Antigen, L1AG, Leukocyte L1 Complex Heavy Chain, LIAG, MAC387, Migration Inhibitory Factor-related Protein 14, MIF Related Protein 14, MRP14, MRP-14, NIF, P14, Protein S100-A9)
4059PPD-L1 Peptide
abx161326-01PD-L1 Blocking Peptide
B2586-1000PD-L1 Binding Peptide, WL12
MBS425798-01CD274 / PD-L1 Immunizing Peptide
NBP1-76769PEP-0.1mgPD-L1 Antibody Blocking Peptide - (Dry Ice)
H-4300.0050Macrophage Inhibitory Peptide

Popular Products